Clinical trial
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic…
NCT00002816 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002816 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia |
| Official title | EXTRAMEDULLARY RELAPSE AND OCCULT BONE MARROW INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE III GROUP-WIDE STUDY |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | cytarabine, dexamethasone, etoposide, idarubicin, ifosfamide, leucovorin calcium, mesna, pegaspargase, therapeutic hydrocortisone, thioguanine and 5 more |
| Enrollment | 120 |
| Start date | Dec 1, 1996 |
| Primary completion | Nov 1, 2002 |
| Completion | Apr 1, 2006 |
| First posted | Jun 23, 2004 |
| Last update posted | Aug 22, 2013 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: